The deletion of β4 integrin resulted in a pronounced inhibition of prostate tumor growth and progression in a mouse model initiated by RB and p53 loss [603]; these inhibitory effects on tumor growth were related to a defective self-renewal of cancer stem cells and to a reduced proliferation of transit-amplifying cells in vivo [603]. This evidence concerns the gene TP53 and neoplasm.